The FDA Office of Combination Products was formed
On Dec. 24, 2002, the FDA’s Office of Combination Products was formed within the Office of the Commissioner,…
On Dec. 24, 2002, the FDA’s Office of Combination Products was formed within the Office of the Commissioner,…
On Dec. 13, 2002, President Bush announced a major smallpox vaccination program to protect the nation against the…
On Dec. 13, 2002, the vaccine that combined the diphtheria, tetanus, acellular pertussis, inactivated polio, and hepatitis B…
On Dec. 12, 2002, a new National Cancer Institute clinical trial has shown that reducing the interval between…
On Dec. 5, 2002, the international Mouse Genome Sequencing Consortium announced the publication of a high-quality draft sequence…
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the FDA for the treatment of…
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…
On Nov. 21, 2002, the estate of Portland philanthropist Bula “Bea” Buck Arveson who died in 2001 at…
On Nov. 12, 2002, Cialisï¾®, a medication to treat male erectile dysfunction, manufactured by Eli Lilly and Company,…
On Oct. 31, 2002, NCI researchers announce they had discovered that a molecule best known for its antimicrobial…
On Oct. 29, 2002, an international research consortium launched a $100 million public-private effort to create the next…
On Oct. 26, 2002, under the Medical Device User Fee and Modernization Act, fees are assessed sponsors of…
On Oct. 16, 2002, patterns of proteins found in patients’ blood may help distinguish between prostate cancer and…
On Oct. 10, 2002, the Oregon Opportunity arrived as Oregon Health & Science University (OHSU) broke ground for…
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
On Sept. 18, 2002, the National Cancer Institute launched the National Lung Screening Trial to compare two ways…
On Sept. 10, 2002, the Public Health Security and Bioterrorism Preparedness and Response Act (P.L. 107-188) was signed…
In Sept. 2002, the Alberta Innovates Centre for Carbohydrate Science (now Alberta Glycomics Centre), began operation with a…
On Aug. 21, 2002, the FDA announced an effort to enhance and update the regulation of manufacturing processes…
On Aug. 21, 2002, the FDA announced an initiative to modernize the regulation of pharmaceutical manufacturing and product…
On Aug. 5, 2002, Richard H. Carmona was sworn in as U.S. Surgeon General.
On Jul. 22, 2002, Amgen announced that the FDA had approved Aranesp (darbepoetin alfa) for the treatment of…
On Jul. 16, 2002, A National Cancer Institute funded trial showed that postmenopausal women who used estrogen replacement…
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
On Jul. 3, 2002, Dr. Julie Louise Gerberding, M.D., M.P.H., became the first woman Director of the Centers…
On Jun. 19, 2002, National Cancer Institute scientists used microarray technology to determine the patterns of genes that…
On Jun. 12, 2002, President George W. Bush signed the Public Health Security and Bioterrorism Preparedness and Response…
On Jun. 8, 2002, the Salt River Pima-Maricopa Indian Community pledged $5 million to the Translational Genomics Research…
In Jun. 2002, the Translational Genomics Research Institute (TGen), a non-profit 501(c)(3) organization focused on developing earlier diagnostics…
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…